Literature DB >> 23729775

Pediatric pharmacokinetics.

Jonathan Wagner1, Susan M Abdel-Rahman.   

Abstract

OBJECTIVES: After reading this article, the reader should be able to 1. Realize that volume of distribution, elimination clearance, and elimination half-life are crucial parameters of pharmacokinetics that must be understood to determine clinical pharmacologic decisions.2. Know that drug disposition is a complicated process of absorption, distribution,metabolism, and excretion. 3. Understand that any abnormality in absorption, distribution, metabolism, and/or excretion can potentially affect the efficacy or toxicity of a drug. 4. Understand that the anatomical and physiologic changes during development must be considered in predicting age-dependent changes in drug disposition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23729775     DOI: 10.1542/pir.34-6-258

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  5 in total

1.  Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forest.

Authors:  Craig A Friesen; Jennifer V Schurman; Susan M Abdel-Rahman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

2.  Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention.

Authors:  Meghan E Whalen; Richard Kajubi; Nona Chamankhah; Liusheng Huang; Francis Orukan; Erika Wallender; Moses R Kamya; Grant Dorsey; Prasanna Jagannathan; Philip J Rosenthal; Norah Mwebaza; Francesca T Aweeka
Journal:  Clin Pharmacol Ther       Date:  2019-07-22       Impact factor: 6.875

Review 3.  Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.

Authors:  Erik Hefti; Javier G Blanco
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

Review 4.  Advances in Drug Discovery and Development for Pediatric Tuberculosis.

Authors:  Daniel Hoagland; Ying Zhao; Richard E Lee
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

5.  Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children's Hospital.

Authors:  Maria Sole Giurin; Marta Paulina Trojniak; Anna Arbo; Marco Carrozzi; Giuseppe Abbracciavento; Lorenzo Monasta; Caterina Zanus
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.